Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of ALYREF in pan cancer as a novel cancer prognostic biomarker and potential regulatory mechanism in gastric cancer

15 Mar 2024

Abstract excerpt

ALYREF is considered as a specific mRNA m5C-binding protein which recognizes m5C sites in RNA and facilitates the export of RNA from the nucleus to the cytoplasm. Expressed in various tissues and highly involved in the transcriptional regulation, ALYREF has the potential to become a novel diagnostic marker and therapeutic target for cancer patients. However, few studies focused on its function during...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38491127
DOI: 10.1038/s41598-024-56895-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of ALYREF in pan cancer as a novel cancer prognostic biomarker and potential regulatory mechanism in gastric cancerPMID 38491127Read ↗

Multi-Omic Analyses of the m5C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular CarcinomaSemantic proximity Read ↗

Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implicationsSemantic proximity Read ↗

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAsSemantic proximity Read ↗

An integrated analysis of whole transcriptome and epigenome data reveals ENSR00000272060, an enhancer RNA, as a potential diagnostic biomarker in gastric cancerSemantic proximity Read ↗

WAKMAR2, a Prognosis-related Enhancer RNA in Gastric CancerSemantic proximity Read ↗

Integrative analysis of a four-component competing endogenous RNA network reveals potential diagnostic and prognostic biomarkers in gastric cancerSemantic proximity Read ↗

Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancerSemantic proximity Read ↗

Serum tRF-27-FDXXE6XRK45 as a Promising Biomarker for the Clinical Diagnosis in Gastric CancerSemantic proximity Read ↗

ELANE is a promising prognostic biomarker that mediates pyroptosis in gastric cancerSemantic proximity Read ↗

The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancerSemantic proximity Read ↗

Prognostic values of E2F mRNA expression in human gastric cancerSemantic proximity Read ↗

Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese populationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.